Quality of life among adult patients living with diabetes in Rwanda: a cross-sectional study in outpatient clinics

Charilaos Lygidakis, Jean Paul Uwizihiwe, Michela Bia, Francois Uwinkindi, Per Kallestrup, Claus Vögele, Charilaos Lygidakis, Jean Paul Uwizihiwe, Michela Bia, Francois Uwinkindi, Per Kallestrup, Claus Vögele

Abstract

Objectives: To report on the disease-related quality of life of patients living with diabetes mellitus in Rwanda and identify its predictors.

Design: Cross-sectional study, part of the baseline assessment of a cluster-randomised controlled trial.

Setting: Outpatient clinics for non-communicable diseases of nine hospitals across Rwanda.

Participants: Between January and August 2019, 206 patients were recruited as part of the clinical trial. Eligible participants were those aged 21-80 years and with a diagnosis of diabetes mellitus for at least 6 months. Illiterate patients, those with severe hearing or visual impairments, those with severe mental health conditions, terminally ill, and those pregnant or in the postpartum period were excluded PRIMARY AND SECONDARY OUTCOME MEASURES: Disease-specific quality of life was measured with the Kinyarwanda version of the Diabetes-39 (D-39) questionnaire. A glycated haemoglobin (HbA1c) test was performed on all patients. Sociodemographic and clinical data were collected, including medical history, disease-related complications and comorbidities.

Results: The worst affected dimensions of the D-39 were 'anxiety and worry' (mean=51.63, SD=25.51), 'sexual functioning' (mean=44.58, SD=37.02), and 'energy and mobility' (mean=42.71, SD=20.69). Duration of the disease and HbA1c values were not correlated with any of the D-39 dimensions. A moderating effect was identified between use of insulin and achieving a target HbA1c of 7% in the 'diabetes control' scale. The most frequent comorbidity was hypertension (49.0% of participants), which had a greater negative effect on the 'diabetes control' and 'social burden' scales in women. Higher education was a predictor of less impact on the 'social burden' and 'energy and mobility' scales.

Conclusions: Several variables were identified as predictors for the five dimensions of quality of life that were studied, providing opportunities for tailored preventive programmes. Further prospective studies are needed to determine causal relationships.

Trial registration number: NCT03376607.

Keywords: general diabetes; primary care; public health.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. International Diabetes Federation (IDF) IDF diabetes atlas. 9th edn Brussels, Belgium: International Diabetes Federation, 2019.
    1. Park PH, Pastakia SD. Access to hemoglobin A1c in rural Africa: a difficult reality with severe consequences. J Diabetes Res 2018;2018:1–5. 10.1155/2018/6093595
    1. Yang W, Zhao W, Xiao J, et al. . Medical care and payment for diabetes in China: enormous threat and great opportunity. PLoS One 2012;7:e39513. 10.1371/journal.pone.0039513
    1. Trikkalinou A, Papazafiropoulou AK, Melidonis A. Type 2 diabetes and quality of life. World J Diabetes 2017;8:120–9. 10.4239/wjd.v8.i4.120
    1. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999;15:205–18. 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>;2-O
    1. El Achhab Y, Nejjari C, Chikri M, et al. . Disease-specific health-related quality of life instruments among adults diabetic: a systematic review. Diabetes Res Clin Pract 2008;80:171–84. 10.1016/j.diabres.2007.12.020
    1. Speight J, Reaney MD, Barnard KD. Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes. Diabet Med 2009;26:315–27. 10.1111/j.1464-5491.2009.02682.x
    1. Kruk ME, Nigenda G, Knaul FM. Redesigning primary care to tackle the global epidemic of noncommunicable disease. Am J Public Health 2015;105:431–7. 10.2105/AJPH.2014.302392
    1. Khunkaew S, Fernandez R, Sim J. Demographic and clinical predictors of health-related quality of life among people with type 2 diabetes mellitus living in northern Thailand: a cross-sectional study. Health Qual Life Outcomes 2019;17:177. 10.1186/s12955-019-1246-2
    1. Redekop WK, Koopmanschap MA, Stolk RP, et al. . Health-Related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002;25:458–63. 10.2337/diacare.25.3.458
    1. Thapa S, Pyakurel P, Baral DD, et al. . Health-Related quality of life among people living with type 2 diabetes: a community based cross-sectional study in rural Nepal. BMC Public Health 2019;19:1171. 10.1186/s12889-019-7506-6
    1. Werfalli M, Kassanjee R, Kalula S, et al. . Diabetes in South African older adults: prevalence and impact on quality of life and functional disability - as assessed using SAGE Wave 1 data. Glob Health Action 2018;11:1449924. 10.1080/16549716.2018.1449924
    1. Wee H-L, Cheung Y-B, Li S-C, et al. . The impact of diabetes mellitus and other chronic medical conditions on health-related quality of life: is the whole greater than the sum of its parts? Health Qual Life Outcomes 2005;3:2. 10.1186/1477-7525-3-2
    1. Hermanns N, Kulzer B, Krichbaum M, et al. . How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 2006;49:469–77. 10.1007/s00125-005-0094-2
    1. Al Hayek AA, Robert AA, Al Saeed A, et al. . Factors associated with health-related quality of life among Saudi patients with type 2 diabetes mellitus: a cross-sectional survey. Diabetes Metab J 2014;38:220–9. 10.4093/dmj.2014.38.3.220
    1. Mngomezulu N, Yang C-C. Quality of life and its correlates in diabetic outpatients in Swaziland. Int Health 2015;7:464–71. 10.1093/inthealth/ihv019
    1. Gross CC, Scain SF, Scheffel R, et al. . Brazilian version of the problem areas in diabetes scale (B-PAID): validation and identification of individuals at high risk for emotional distress. Diabetes Res Clin Pract 2007;76:455–9. 10.1016/j.diabres.2006.09.022
    1. Arifin B, Idrus LR, van Asselt ADI, et al. . Health-related quality of life in Indonesian type 2 diabetes mellitus outpatients measured with the Bahasa version of EQ-5D. Qual Life Res 2019;28:1179–90. 10.1007/s11136-019-02105-z
    1. National Institute of Statistics of Rwanda (NISR), National Institute of Statistics of Rwanda . The statistical Yearbook, 2019 edition, 2019. Available:
    1. Uwimana J, Struthers P. Met and unmet palliative care needs of people living with HIV/AIDS in Rwanda. Sahara J 2007;4:575–85. 10.1080/17290376.2007.9724819
    1. Biraguma J, Mutimura E, Frantz JM. Health-Related quality of life and associated factors in adults living with HIV in Rwanda. Sahara J 2018;15:110–20. 10.1080/17290376.2018.1520144
    1. Krumme AA, Kaigamba F, Binagwaho A, et al. . Depression, adherence and attrition from care in HIV-infected adults receiving antiretroviral therapy. J Epidemiol Community Health 2015;69:284–9. 10.1136/jech-2014-204494
    1. Lygidakis C, Uwizihiwe JP, Kallestrup P, et al. . Community- and mHealth-based integrated management of diabetes in primary healthcare in Rwanda (D²Rwanda): the protocol of a mixed-methods study including a cluster randomised controlled trial. BMJ Open 2019;9:e028427. 10.1136/bmjopen-2018-028427
    1. Ministry of Health of Rwanda, Rwanda Biomedical Center (RBC) . National guideline for management of non communicable diseases (NCDS). 2016th ED. Kigali, 2016. Available:
    1. Amendezo E, Walker Timothy D, Karamuka V, et al. . Effects of a lifestyle education program on glycemic control among patients with diabetes at Kigali university Hospital, Rwanda: a randomized controlled trial. Diabetes Res Clin Pract 2017;126:129–37. 10.1016/j.diabres.2017.02.001
    1. Boyer JG, Earp JA. The development of an instrument for assessing the quality of life of people with diabetes. Diabetes-39. Med Care 1997;35:440–53. 10.1097/00005650-199705000-00003
    1. Watkins K, Connell CM. Measurement of health-related QOL in diabetes mellitus. Pharmacoeconomics 2004;22:1109–26. 10.2165/00019053-200422170-00002
    1. Beaton DE, Bombardier C, Guillemin F, et al. . Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 2000;25:3186–91. 10.1097/00007632-200012150-00014
    1. Queiroz FAde, Pace AE, Santos CBdos. Cross-cultural adaptation and validation of the instrument Diabetes - 39 (D-39): brazilian version for type 2 diabetes mellitus patients - stage 1. Rev Lat Am Enfermagem 2009;17:708–15. 10.1590/s0104-11692009000500018
    1. Nyanzi R, Wamala R, Atuhaire LK. Diabetes and quality of life: a Ugandan perspective. J Diabetes Res 2014;2014:1–9. 10.1155/2014/402012
    1. Fritz CO, Morris PE, Richler JJ. Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen 2012;141:2–18. 10.1037/a0024338
    1. Akoglu H User’s guide to correlation coefficients. Turk J Emerg Med 2018;18:91–3. 10.1016/j.tjem.2018.08.001
    1. Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg 2018;126:1763–8. 10.1213/ANE.0000000000002864
    1. Jing X, Chen J, Dong Y, et al. . Related factors of quality of life of type 2 diabetes patients: a systematic review and meta-analysis. Health Qual Life Outcomes 2018;16:189. 10.1186/s12955-018-1021-9
    1. Reba K, Argaw Z, Walle B, et al. . Health-Related quality of life of patients with diagnosed type 2 diabetes in Felege Hiwot referral Hospital, North West Ethiopia: a cross-sectional study. BMC Res Notes 2018;11:544. 10.1186/s13104-018-3625-x
    1. Walker RJ, Lynch CP, Strom Williams J, et al. . Meaning of illness and quality of life in patients with type 2 diabetes. J Diabetes Complications 2015;29:665–9. 10.1016/j.jdiacomp.2015.04.006
    1. Choi YJ, Lee MS, An SY, et al. . The relationship between diabetes mellitus and health-related quality of life in Korean adults: the fourth Korea National health and nutrition examination survey (2007-2009). Diabetes Metab J 2011;35:587–94. 10.4093/dmj.2011.35.6.587
    1. Daya R, Bayat Z, Raal FJ. Effects of diabetes mellitus on health-related quality of life at a tertiary hospital in South Africa: a cross-sectional study. S Afr Med J 2016;106:918–28. 10.7196/SAMJ.2016.v106i9.9899
    1. Daher AM, AlMashoor SAH, Winn T. Glycaemic control and quality of life among ethnically diverse Malaysian diabetic patients. Qual Life Res 2015;24:951–8. 10.1007/s11136-014-0830-5
    1. Robertson RP Beta-Cell deterioration during diabetes: what's in the gun? Trends Endocrinol Metab 2009;20:388–93. 10.1016/j.tem.2009.05.004
    1. Saito I, Inami F, Ikebe T, et al. . Impact of diabetes on health-related quality of life in a population study in Japan. Diabetes Res Clin Pract 2006;73:51–7. 10.1016/j.diabres.2005.11.015
    1. Shim YT, Lee J, Toh MPHS, Toh M, et al. . Health-Related quality of life and glycaemic control in patients with type 2 diabetes mellitus in Singapore. Diabet Med 2012;29:e241–8. 10.1111/j.1464-5491.2012.03689.x
    1. Camacho F, Anderson RT, Bell RA, et al. . Investigating correlates of health related quality of life in a low-income sample of patients with diabetes. Qual Life Res 2002;11:783–96. 10.1023/A:1020858102483
    1. Tapela N, et al. Diabetes in rural Rwanda: high retention and positive outcomes after 24 months of follow-up in the setting of chronic care integration. Int J Diabetes Clin Res 2016;3 10.23937/2377-3634/1410058
    1. Camara A, Baldé NM, Sobngwi-Tambekou J, et al. . Poor glycemic control in type 2 diabetes in the South of the Sahara: the issue of limited access to an HbA1c test. Diabetes Res Clin Pract 2015;108:187–92. 10.1016/j.diabres.2014.08.025
    1. Solli O, Stavem K, Kristiansen IS. Health-Related quality of life in diabetes: the associations of complications with EQ-5D scores. Health Qual Life Outcomes 2010;8:18. 10.1186/1477-7525-8-18
    1. Mikailiūkštienė A, Juozulynas A, Narkauskaitė L, et al. . Quality of life in relation to social and disease factors in patients with type 2 diabetes in Lithuania. Med Sci Monit 2013;19:165–74. 10.12659/MSM.883823
    1. Papadopoulos AA, Kontodimopoulos N, Frydas A, et al. . Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health 2007;7:186. 10.1186/1471-2458-7-186
    1. Gatege R, Amendezo E, Twagirumukiza M. Clinical patterns and complications of African diabetic patients: preliminary data from Kigali university teaching Hospital, Rwanda. African J Diabetes Med 2012;20:39–42.
    1. Mbanya J, Ramiaya K. Diabetes mellitus : Jamison D, Feachem R, Makgoba M, Disease and mortality in sub-Saharan Africa. Washington (DC: The International Bank for Reconstruction and Development/The World Bank, 2006.
    1. Lalkhen H, Mash R. Multimorbidity in non-communicable diseases in South African primary healthcare. S Afr Med J 2015;105:134–8. 10.7196/SAMJ.8696
    1. Chen G, Iezzi A, McKie J, et al. . Diabetes and quality of life: comparing results from utility instruments and Diabetes-39. Diabetes Res Clin Pract 2015;109:326–33. 10.1016/j.diabres.2015.05.011
    1. Alfian SD, Sukandar H, Lestari K, et al. . Medication adherence contributes to an improved quality of life in type 2 diabetes mellitus patients: a cross-sectional study. Diabetes Ther 2016;7:755–64. 10.1007/s13300-016-0203-x
    1. Javanbakht M, Abolhasani F, Mashayekhi A, et al. . Health related quality of life in patients with type 2 diabetes mellitus in Iran: a national survey. PLoS One 2012;7:e44526. 10.1371/journal.pone.0044526
    1. Gill GV, Mbanya J-C, Ramaiya KL, et al. . A sub-Saharan African perspective of diabetes. Diabetologia 2009;52:8–16. 10.1007/s00125-008-1167-9
    1. Mauvais-Jarvis F, Sobngwi E, Porcher R. Ketosis-Prone type 2 diabetes in patients of sub-Saharan African origin. Diabetes 2004;53:645–53.
    1. Huang I-C, Hwang C-C, Wu M-Y, et al. . Diabetes-specific or generic measures for health-related quality of life? Evidence from psychometric validation of the D-39 and SF-36. Value Health 2008;11:450–61. 10.1111/j.1524-4733.2007.00261.x

Source: PubMed

Подписаться